Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
Plos One
Liu, Jie J; Bayer, Jason D JD; Aschar-Sobbi, Roozbeh R; Wauchop, Marianne M; Spears, Danna D; Gollob, Michael M; Vigmond, Edward J EJ; Tsushima, Robert R; Backx, Peter H PH; Chauhan, Vijay S VS